T-group (topology)
5092.1.1 Domain in virus attachment proteins
Ligands and drugs
713
Member domains
272
with ligand contacts (≤ 4 Å)
38.1% of members
258
with DrugDomain annotations
36.2% of members
194
with a DrugBank compound
27.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5092.1.1 belongs to X-group 5092 Domain in virus attachment proteins, which binds 6.6 ligand superclasses per 20 proteins, narrower than 66% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03721 | SIA | N-acetyl-alpha-neuraminic acid | 33 |
| DB04265 | SLB | N-acetyl-beta-neuraminic acid | 32 |
| DB08357 | P4G | Diethylene glycol diethyl ether | 11 |
| DB00130 | GLN | L-Glutamine | 6 |
| DB00142 | GLU | Glutamic acid | 4 |
| DB00160 | ALA | Alanine | 3 |
| DB01822 | DTD | (4R,5R)-1,2-dithiane-4,5-diol | 2 |
| DB04237 | TAM | Tris(Hydroxyethyl)Aminomethane | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 52 |
| SIA | N-acetyl-alpha-neuraminic acid | 31 |
| SLB | N-acetyl-beta-neuraminic acid | 31 |
| BR | BROMIDE ION | 15 |
| MGmetal | MAGNESIUM ION | 15 |
| CL | CHLORIDE ION | 12 |
| P4G | 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE | 11 |
| 18D | 3,5-dideoxy-5-(propanoylamino)-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid | 9 |
| NAmetal | SODIUM ION | 9 |
| ANA | methyl 4-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid | 6 |
| GLN | GLUTAMINE | 6 |
| CAmetal | CALCIUM ION | 5 |
| 423 | (1-{2-[bis(2-{4-[({(6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl}oxy)methyl]-1H-1,2,3-triazol-1-yl}ethyl)amino]ethyl}-1H-1,2,3-triazol-4-yl)methyl (6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranosidonic acid | 3 |
| 425 | 2-(1-{2-[bis(2-{4-[2-({(6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl}oxy)ethyl]-1H-1,2,3-triazol-1-yl}ethyl)amino]ethyl}-1H-1,2,3-triazol-4-yl)ethyl (6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranosidonic acid | 3 |
| 42D | 3,5-dideoxy-5-[(methoxycarbonyl)amino]-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid | 3 |
| GLU | GLUTAMIC ACID | 3 |
| MNA | 2-O-methyl-5-N-acetyl-alpha-D-neuraminic acid | 3 |
| PKM | 4-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid | 3 |
| SIO | methyl 4,9-di-O-acetyl-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid | 3 |
| DTD | DITHIANE DIOL | 2 |